Phosphate Binders in CKD: ‟New Kids on the Block”
DOI:
https://doi.org/10.53778/pjkd31089الكلمات المفتاحية:
hyperphosphatemia، mineral bone disease، sevelamer، ferric sitrate، lanthanum، sucro ferricoxyhydroxideالملخص
Phosphate control is essential component of dietary and medical management of chronic kidney disease (CKD) patients. Hyperphosphatemia has a significant effect on morbidity and mortality of CKD patients. This review takes us through the different older and newer medications available for management of hyperphosphatemia.
التنزيلات
منشور
2021-02-05
إصدار
القسم
Review Article
الرخصة
الحقوق الفكرية (c) 2021 Muhammad Umair Afzal, Shafeeq Cheema
هذا العمل مرخص بموجب Creative Commons Attribution-NonCommercial 4.0 International License.
كيفية الاقتباس
Phosphate Binders in CKD: ‟New Kids on the Block”. (2021). Pakistan Journal of Kidney Diseases, 3(10). https://doi.org/10.53778/pjkd31089
